These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Procainamide induction of a systemic lupus erythematosus-like syndrome. Presentation of six cases, review of the literature, and analysis and followup of reported cases. Dubois EL Medicine (Baltimore); 1969 May; 48(3):217-28. PubMed ID: 5769742 [No Abstract] [Full Text] [Related]
28. The gingival hyperplasia resulting from diphenylhydantoin in children and adults. Matsumoto K; Nakagawa K; Kaneko Z Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):369-71. PubMed ID: 1176242 [TBL] [Abstract][Full Text] [Related]
29. Procainamide and lupus erythematosus. Sokol SA J Maine Med Assoc; 1973 Mar; 64(3):54-5 passim. PubMed ID: 4540169 [No Abstract] [Full Text] [Related]
30. Angioimmunoblastic lymphadenopathy in a patient taking diphenylhydantoin. Tsung SH; Lin JI Ann Clin Lab Sci; 1981; 11(6):542-5. PubMed ID: 6976773 [TBL] [Abstract][Full Text] [Related]
31. [Medicaments as iatrogenic factors in the onset of lupoid syndromes]. Galea G; Geavlete A Med Interna (Bucur); 1974 Jan; 26(1):89-94. PubMed ID: 4821155 [No Abstract] [Full Text] [Related]
32. [Differential diagnosis of septic endocarditis, rheumatism and systemic lupus erythematosus]. Butkevich OM Vopr Revm; 1971; 11(1):51-8. PubMed ID: 5091497 [No Abstract] [Full Text] [Related]
33. [Oral lupus erythematosus. Description and analysis of 11 cases]. Togliatto M; Carrozzo M; Conrotto D; Pagano M; Gandolfo S Minerva Stomatol; 2000; 49(1-2):35-40. PubMed ID: 10932906 [TBL] [Abstract][Full Text] [Related]